FR2696179B1 - Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes. - Google Patents

Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes.

Info

Publication number
FR2696179B1
FR2696179B1 FR9311488A FR9311488A FR2696179B1 FR 2696179 B1 FR2696179 B1 FR 2696179B1 FR 9311488 A FR9311488 A FR 9311488A FR 9311488 A FR9311488 A FR 9311488A FR 2696179 B1 FR2696179 B1 FR 2696179B1
Authority
FR
France
Prior art keywords
thioalkylthiocarbacephalosporin
prophylaxis
preparations
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9311488A
Other languages
English (en)
Other versions
FR2696179A1 (fr
Inventor
Tadatoshi Kubota
Masaharu Kume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR2696179A1 publication Critical patent/FR2696179A1/fr
Application granted granted Critical
Publication of FR2696179B1 publication Critical patent/FR2696179B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9311488A 1992-09-30 1993-09-28 Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes. Expired - Fee Related FR2696179B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26147892A JP3238209B2 (ja) 1992-09-30 1992-09-30 チオメチルチオカルバセファロスポリン誘導体

Publications (2)

Publication Number Publication Date
FR2696179A1 FR2696179A1 (fr) 1994-04-01
FR2696179B1 true FR2696179B1 (fr) 1996-01-05

Family

ID=17362465

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9311488A Expired - Fee Related FR2696179B1 (fr) 1992-09-30 1993-09-28 Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes.

Country Status (8)

Country Link
US (1) US5362724A (fr)
JP (1) JP3238209B2 (fr)
BE (1) BE1007544A3 (fr)
CH (1) CH687205A5 (fr)
ES (1) ES2103222B1 (fr)
FR (1) FR2696179B1 (fr)
GB (1) GB2271564B (fr)
IT (1) IT1271421B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0133937B1 (ko) * 1989-02-22 1998-04-18 말키 예후다 상이 박힌 비누 제조방법
US5565445A (en) * 1995-02-22 1996-10-15 Merck & Co., Inc. 3-thioheteroaryl 1-carba-1-dethiacephalosporin compounds, compositions and methods of use
CN101835777A (zh) 2007-10-25 2010-09-15 尔察祯有限公司 碳头孢烯β-内酰胺抗生素
WO2010030811A2 (fr) * 2008-09-10 2010-03-18 Achaogen, Inc. Antibiotiques de type β-lactame à base de carbacéphème
WO2010030810A1 (fr) * 2008-09-10 2010-03-18 Achaogen, Inc. Antibiotiques de type béta-lactame à base de carbacéphème

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd ３位置換カルバセフエム化合物
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
IE65926B1 (en) * 1990-07-19 1995-11-29 Shionogi & Co Thioalkylthio cephalosporin derivatives
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents

Also Published As

Publication number Publication date
ITMI932073A1 (it) 1995-03-29
US5362724A (en) 1994-11-08
IT1271421B (it) 1997-05-28
BE1007544A3 (fr) 1995-08-01
GB9319338D0 (en) 1993-11-03
JP3238209B2 (ja) 2001-12-10
ES2103222B1 (es) 1998-06-16
CH687205A5 (fr) 1996-10-15
GB2271564A (en) 1994-04-20
GB2271564B (en) 1996-03-06
FR2696179A1 (fr) 1994-04-01
JPH06107660A (ja) 1994-04-19
ITMI932073A0 (it) 1993-09-29
ES2103222A1 (es) 1997-09-01

Similar Documents

Publication Publication Date Title
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
BG101118A (en) Therapeutical compounds
FR2665453B1 (fr) Polylactides purifies, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23490A1 (fr) Derives de lipopeptide, procede pour leur preparation, composition les contenant et leur utilisation .
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
RU93004457A (ru) 1-карба-(1-детиа)-цефемы и промежуточные продукты для их получения
MA24339A1 (fr) Procede de preparation de medicaments destines au traitement d'infections bacteriennes en pediaterie
DK617086D0 (da) Antibiotikum a 40926 mannosyl-aglycon og additionssalte deraf samt laegemiddel indeholdende en saadan forbindelse
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
FR2696179B1 (fr) Derives de thioalkylthiocarbacephalosporine, procede pour leurs preparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bacteriennes.
FR2588868B1 (fr) Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant
FR2515518B1 (fr) Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant
FR2691461B1 (fr) Dérivés de cycloheptimidazole, procédé pour les préparer et composition pharmaceutique et agents thérapeutiques les contenant.
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
BE889618A (fr) Derives condenses d'as-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
MA26657A1 (fr) Derives de cephalosporine, procede pour les preparer, medicaments les contenant, et leur utilisation dans le traitement de la prophylaxie de maladies infectieuses.
ATE36240T1 (de) Immunomodulierendes arzneimittel biologischer herkunft und verfahren zu seiner herstellung.
FR2693196B1 (fr) Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse